Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$525,396,775
-$48,079,884 QoQ
Shares Held
21,818,803
+6.8% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#27
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $3,146,467,914 across 15 Drug Manufacturers - General names. PFE ranks #1 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
21,818,803 | $525,396,775 | |
| 2 | AMGN |
Amgen Inc
|
1,131,395 | $409,700,757 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,991,633 | $377,962,913 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,981,822 | $344,672,583 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,591,856 | $333,053,496 | |
| 6 | JNJ |
Johnson & Johnson
|
1,284,877 | $326,320,211 | |
| 7 | LLY |
ELI LILLY & Co
|
217,393 | $260,747,707 | |
| 8 | ABBV |
AbbVie Inc.
|
800,818 | $201,517,841 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $525,396,775 | 21,818,803 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $573,476,659 | 20,422,958 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $466,412,283 | 18,731,417 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $464,644,667 | 18,235,662 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $423,587,649 | 17,474,738 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $423,676,488 | 16,719,672 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $381,291,441 | 14,372,086 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $345,703,927 | 11,945,540 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $334,415,784 | 11,951,958 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $398,161,800 | 14,348,173 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $587,222,288 | 20,396,745 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $716,289,564 | 21,594,500 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $714,926,468 | 19,490,907 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $429,659,863 | 10,530,879 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $469,752,589 | 9,167,693 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $251,333,678 | 5,743,457 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $301,508,519 | 5,750,687 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $409,483,357 | 7,909,665 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $224,220,939 | 3,797,137 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $189,036,089 | 4,395,166 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $191,068,727 | 4,879,181 | Shares | Other | 2021-10-12 | |
| 2021-03-31 | $211,170,565 | 5,864,687 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $325,863,764 | 8,852,588 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $314,838,713 | 8,578,720 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $248,739,314 | 7,606,699 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $151,243,567 | 4,633,694 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||